Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 3
1(33.3%)
N/A
1(33.3%)
Phase 1
1(33.3%)
3Total
Phase 3(1)
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03131960Not ApplicableCompleted

Pivotal Study of VNS During Rehab After Stroke (VNS-REHAB)

Role: collaborator

NCT01004029Phase 3Completed

Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery

Role: collaborator

NCT04035135Phase 1Completed

A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)

Role: collaborator

All 3 trials loaded